Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-94,528
Closed -$7.15M 27
2026
Q1
$7.15M Buy
94,528
+62,028
+191% +$4.66M 8.68% 4
2025
Q4
$2.42M Buy
32,500
+29,500
+983% +$2.16M 1.84% 16
2025
Q3
$202K Buy
+3,000
New +$199K 0.2% 70
2022
Q2
Sell
-5,506
Closed -$423K 354
2022
Q1
$423K Buy
+5,506
New +$396K 0.26% 120

Other funds holding HOLX

Fifth Lane Capital's HOLX Position: Q2 2026 in Review

Fifth Lane Capital sold out of Hologic (HOLX) in Q2 2026, closing a stake of 94,528 shares — an estimated $7.15M sold.

Fifth Lane Capital first reported a position in HOLX in Q1 2022 and held it in 4 quarters. The position peaked at $7.15M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Fifth Lane Capital reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Fifth Lane Capital sold 94,528 Hologic shares in Q2 2026, an estimated $7.15M.
  • Fifth Lane Capital first reported a position in Hologic in Q1 2022 and held it in 4 quarters.
  • Fifth Lane Capital's Hologic position peaked at $7.15M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Fifth Lane Capital's 13F filing for Q2 2026, filed 6 Aug 2026.